• 6 ways to bolster FDA's guidance for diversifying participation in clinical trials

    13 days ago - By The Healthcare Guys

    FDA's draft guidance on diversifying clinical trial data services is a positive step in the right direction, and the agency must continue encouraging diversity in clinical trials. However, more can be done to further bolster the guidance and ensure that it has a real impact on diversifying clinical trial participation.
    Why is it important to diversify clinical trial participation?
    Clinical trials are vital for advancing medical knowledge and developing new treatments, but they can only do so if they enroll a diverse range of participants. This is why it is critical to diversify clinical...
    Read more ...